IMMP Stock Analysis: Buy, Sell, or Hold?
IMMP - Immutep Limited American Depositary Shares
$0.40
0.01 (1.94%)
▲
5d:
-2.39%
30d:
+3.15%
90d:
-29.94%
BUY
MODERATE Confidence
Analysis Updated: Jul 23, 2026 12:00 AM ET
Earnings: Sep 04, 2026
Get Alerted When IMMP Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: IMMP shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
💡 BUY OPPORTUNITY: IMMP shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
In-depth Analysis How we analyze
Valuation Analysis: IMMP is currently trading at $0.40, which is considered fair relative to its 30-day fair value range of $0.38 to $0.43.
Technical Outlook: Technically, IMMP is in a downtrend. Immediate support is located at $0.38, while resistance sits at $0.46.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $1.50 (+282.3%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, IMMP is in a downtrend. Immediate support is located at $0.38, while resistance sits at $0.46.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $1.50 (+282.3%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$0.38 -
$0.43
Company Quality Score
44/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
74.7%
All Signals
- NEUTRAL: Price in fair range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 282.3% below Wall St target ($1.50)
Trading Range Analysis
30-Day Trading Range
$0.38 -
$0.43
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$0.38
Resistance Level
$0.46
Current Trend
Downtrend
Technical data as of
Jul 23, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-1.96
Wall Street Target
$1.50
(+282.3%)
Revenue Growth (YoY)
91.5%
Share & Embed Analysis
Last updated: July 24, 2026 10:24 AM ET
Data refreshes hourly during market hours. Next update: 11:24 AM
Data refreshes hourly during market hours. Next update: 11:24 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is IMMP showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NTLA
Intellia Therapeutics Inc |
STRONG BUY
29 analysts |
$26 | 52 HOLD |
|
RNA
Atrium Therapeutics, Inc… |
STRONG BUY
15 analysts |
$25 | 59 HOLD |
|
NRIX
Nurix Therapeutics Inc |
STRONG BUY
18 analysts |
$33 | 53 HOLD |
|
DYN
Dyne Therapeutics Inc |
STRONG BUY
14 analysts |
$39 | 55 HOLD |
|
IMCR
Immunocore Holdings Ltd |
STRONG BUY
17 analysts |
$63 | 56 HOLD |
